RxDoctor Payments Data

Timothy Allen, MD

Dermatology · Minneapolis, MNNPI 1093203184

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.6% of the total across 142 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,078 and has fallen 58.0% since, to $872 in 2025. Among dermatology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,358in general payments, 2019–2025

Across 142 payments — averaging $23.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$629
  • Regeneron Healthcare Solutions, Inc.$462
  • Lilly USA, LLC$402
  • Johnson & Johnson$359
  • AbbVie$355
  • Pfizer$224
  • plus $927 from 11 others

What the payments were for

  • Food & beverage$3,27898%
  • Education$812%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,358 in reported general payments places this provider in the 90th percentile of 273 dermatology providers in Minnesota.

See all dermatology providers in Minnesota

Medicare billing

Part B allowed, 2024
$198,849
Medicare patients
456
Services billed
9,879

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Triamcinolone Acetonide126$1,913
Tacrolimus18$1,814
Clobetasol Propionate30$1,558
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc55$1,402
Ciclopirox28$1,045
Fluocinonide22$1,036
Nystatin44$851
Metronidazole15$753
Fluocinolone AcetonideFluocinolone/Shower Cap14$609
Clindamycin Phosphate19$542
Ketoconazole33$542
NystopNystatin19$498
ValacyclovirValacyclovir Hcl15$369
Doxycycline Hyclate24$367
Hydrocortisone24$331

Paid to pharmacies, not to this prescriber.

Other dermatology in Minneapolis

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →